MarketCap
Facebook
X
Telegram
Nano-X Imaging Ltd. Gross Profit | NNOX
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Nano-X Imaging Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.8 M | -10.6 M | -6.59 M | -6.88 M | -1.51 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.51 M | -12.8 M | -7.68 M |
Quarterly Gross Profit Nano-X Imaging Ltd.
| 2025-Q4 | 2024-Q4 | 2023-Q4 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.8 M | -10.6 M | -6.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -6.59 M | -12.8 M | -10 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M |  USA |
 |
Bruker Corporation
BRKR
|
1.58 B | $ 64.0 | 7.26 % | $ 9.72 B | USA |
 |
Boston Scientific Corporation
BSX
|
13.9 B | $ 44.68 | 0.06 % | $ 66.1 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
290 M | $ 8.7 | 0.06 % | $ 634 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 14.61 | 13.03 % | $ 414 M | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 45.18 | 3.31 % | $ 1.4 B | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 4.3 | 1.63 % | $ 268 M | USA |
 |
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 16.08 | 0.75 % | $ 576 M | USA |
 |
Medigus Ltd.
MDGS
|
6.68 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
Electromed
ELMD
|
57.9 M | $ 27.86 | 1.05 % | $ 230 M | USA |
 |
Establishment Labs Holdings
ESTA
|
146 M | $ 65.58 | 3.69 % | $ 1.94 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 85.73 | 0.32 % | $ 50.1 B | USA |
 |
Nemaura Medical
NMRD
|
-1.48 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 5.57 | 0.43 % | $ 753 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.52 M | $ 2.9 | 0.69 % | $ 63.9 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 15.88 | 2.25 % | $ 1.22 B | USA |
 |
Inogen
INGN
|
154 M | $ 5.23 | 2.75 % | $ 139 M | USA |
 |
InMode Ltd.
INMD
|
291 M | $ 14.19 | 0.21 % | $ 917 M | Israel |
 |
Inspire Medical Systems
INSP
|
779 M | $ 68.81 | 0.59 % | $ 2.02 B | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 0.63 | 2.51 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
64.3 M | $ 85.2 | 0.08 % | $ 1.08 B | USA |
 |
AxoGen
AXGN
|
167 M | $ 43.32 | 0.48 % | $ 1.99 B | USA |
 |
Align Technology
ALGN
|
2.71 B | $ 145.63 | 4.36 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
14.1 M | $ 7.08 | 0.28 % | $ 84.7 M | USA |
 |
Sientra
SIEN
|
3.23 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
127 M | - | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
19.6 B | $ 88.51 | 0.32 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
346 M | $ 4.71 | 0.1 % | $ 696 M | USA |
 |
Surgalign Holdings
SRGA
|
40.3 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
635 M | - | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
26.9 M | $ 1.67 | 1.83 % | $ 69.9 M | USA |
 |
InspireMD
NSPR
|
2.65 M | $ 0.7 | 0.37 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
566 M | $ 9.16 | 0.11 % | $ 363 M |  Curacao |
 |
Outset Medical
OM
|
46.8 M | $ 3.13 | 1.29 % | $ 47.6 K | USA |
 |
Insulet Corporation
PODD
|
1.94 B | $ 135.78 | 0.01 % | $ 9.55 B | USA |
 |
Profound Medical Corp.
PROF
|
11.4 M | $ 5.6 | 1.66 % | $ 169 M | Canada |
 |
Quanterix Corporation
QTRX
|
65 M | $ 3.18 | 0.63 % | $ 136 M | USA |
 |
Natus Medical Incorporated
NTUS
|
274 M | - | 1.94 % | $ 1.05 B | USA |
 |
AVITA Medical
RCEL
|
58.8 M | $ 11.58 | 5.75 % | $ 323 M |  Australia |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
33 M | $ 2.83 | 1.37 % | $ 116 M | USA |
 |
Sintx Technologies
SINT
|
461 K | $ 1.87 | 5.06 % | $ 5.19 M | USA |
 |
Accuray Incorporated
ARAY
|
111 M | $ 0.22 | 0.4 % | $ 27 M | USA |
 |
Smith & Nephew plc
SNN
|
4.19 B | $ 26.68 | 0.02 % | $ 23.1 B | Britain |
 |
Inari Medical
NARI
|
435 M | - | - | $ 4.23 B | USA |